Detalles de la búsqueda
1.
Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy.
J Pharmacol Exp Ther
; 374(1): 211-222, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32345620
2.
INCB040093 Is a Novel PI3Kδ Inhibitor for the Treatment of B Cell Lymphoid Malignancies.
J Pharmacol Exp Ther
; 364(1): 120-130, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29127109
3.
Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infection.
J Pharmacol Exp Ther
; 338(1): 228-39, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21459966
4.
INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ).
ACS Med Chem Lett
; 10(11): 1554-1560, 2019 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31749910
Resultados
1 -
4
de 4
1
Próxima >
>>